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Oral cancer is one of the most common malignancy in India and is the major 
form of cancer worldwide. It contributes to about 30-40% of all cancers. In India, the 
age standardized incidence rate of oral cancer patients is about 12.6 per 100,000 
population and prevalence is also very high. It is 4 times higher than in other 
countries. The important etiologic agents of oral cancer in India are tobacco, chewing 
with betel quid or tobacco smoking and alcohol consumption. Oral squamous cell 
carcinoma (OSCC) makes upto 90 % of all oral cancers. Even though various theories 
have been established, free radicals play a very important role in the carcinogenesis 
(Ganesan and Kumar, 2014).  
Free radicals are released from various biochemical reactions taking place in 
our body and also from respiratory chain as a result of occasional leakage. It can be an 
atom or molecule with one or more unpaired electron. Despite their short half life, 
they show a high reactivity and damaging activity towards micromolecules like 
proteins and lipids. These free radicals can be oxygen derived and are called reactive 
oxygen species (ROS) (Ganesan and Kumar, 2014). 
Oxidative stress is an imbalance between the production of ROS and the cell’s 
oxidant capacity. This may initiate or promote carcinogenesis in the cell by 
mutagenesis, cytotoxicity and changes in gene expression. Hence, free radicals are 
believed to play an important role in the disease progression. Free radicals can 
produce lipid peroxidation in membrane, oxidative modification of proteins and DNA 
damage, which indirectly induces cell death, mutation and carcinogenesis (Gurudath 
et al., 2012).  
During lipid peroxidation, free radicals attract the hydrogen atom from the 
polyunsaturated fatty acid (PUFA) of the plasma membrane and produces peroxide, 
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which are themselves unstable and more reactive thereby resulting in loss of 
membrane functions. Lipid peroxidation and continuous degradation produce 
Malondialdehyde (MDA) and 4 hydroxy-2-nonenal (4-HNE). 
The most widely used method of estimating free radical activity and lipid 
peroxidation is to determine the concentration of MDA. It is a marker for measuring 
oxidative stress (Mahadevan and Velavan et al., 2012).       
MDA, a highly reactive three carbon dialdehyde, CH2 (CHO)2 readily 
combines with several functional groups on molecules including proteins, 
lipoproteins, and DNA. MDA-modified proteins may show altered physico-chemical 
behavior and antigenicity. It has been known to be mutagenic in bacterial and 
mammalian cells and carcinogenic in rats (Choudhari et al., 2014).  
Numerous compounds and enzymes work to overcome the damage caused by 
ROS and to protect cellular components from oxidative damage. Antioxidants acts as 
the first line of defense against free radical damage. They are essential for maintaining 
optimum health and well‑being. Superoxide dismutase (SOD), glutathione peroxidase 
(GPx) and catalase (CAT) are the three major enzymatic antioxidants, responsible for 
scavenging free radicals and nascent oxygen. These enzymes catalyze decomposition 
of ROS (Gurudath et al., 2012). 
GPx contains selenium in its active center and has a high degree of affinity for 
hydrogen peroxide (H2O2) compared with CAT. GPx, a selenium dependent enzyme, 
removes both H2O2 and lipid peroxide by catalyzing a redox reaction using 
glutathione. Therefore H2O2 mediated intracellular DNA damage is prevented, which 
is thought to be a prerequisite for carcinogenesis. GPx inactivation has been reported 
to be caused by oxidative damage to the cell membrane. SOD metabolizes free 
                                                                                                                                       
INTRODUCTION 
 
3 
 
radicals and dismutates superoxide anions (O2
-
) to H2O2. This protects the cells 
against O2
-
 mediated lipid peroxidation. CAT neutralizes the toxicity by acting on 
H2O2 and decomposing it. It has been reported that superoxide radicals inhibit CAT 
activity and H2O2 suppresses SOD activity in the cell (Beevi et al., 2004). 
 Redox modulation is observed by distinctive changes in the activities of these 
enzymes in oxidative stress. Therefore an overall balance between ROS production 
and removal may be more important in various cancers including OSCC (Gurudath 
et al., 2012). 
 The most routinely used diagnostic procedure in the laboratory involves the 
analysis of the cellular and chemical constituents of blood. Other biologic fluids are 
also utilized for the diagnosis of various diseases, out of which saliva offers some 
distinctive advantages (Mahadevan and Velavan, 2012). Saliva based diagnostics are 
non-invasive, non-infectious and cost-effective screening tools. It is a potential 
substitute to blood and serum based diagnostic technologies (Kaur et al., 2016). The 
exchange between plasma and saliva takes place in the salivary ducts, which are 
separated from the systemic circulation by a thin layer of epithelial cells (Lee and 
Wong, 2009). Saliva acts as a diagnostic fluid for many oral and systemic diseases 
like diabetes, cancer, cardiovascular, metabolic and neurological diseases 
(Mahadevan and Velavan, 2012). Numerous studies confirm that saliva can be 
useful for the early detection, diagnosis, prognosis, and prediction of oral precancer 
and cancer (Kaur et al., 2016). 
 Oxidative stress biomarkers have been quantified in plasma, whole blood, 
urine, respired gases, muscle and other skeletal tissues. One possible biofluid that has 
the potential to be utilized for measuring a variety of antioxidants and stress related 
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biomarkers but still under investigation is saliva. Saliva is an attractive biospecimen 
due to its ease of collection and adequate amount is produced by the human body for 
examination (Evans and Omaye, 2017). Saliva is one of the most complex, versatile 
and important body fluid. It reflects a large range of physiological needs and 
information. Hence, known as the “mirror of the body” (Wang and Gao et al., 2014).   
In India, salivary analysis is not given much importance and there are only 
limited studies on analysis of salivary oxidative stress markers in cancer. As saliva is 
in proximity to oral neoplasms and premalignant lesions, it could be an ideal tool for 
screening, diagnosis, and management of oral cancer (Shivashankara and Kavya, 
2011).  
Studies have proved that there was an increase in serum and salivary levels of 
MDA in oral cancer patients compared to normal healthy individuals. Only limited 
studies exist to compare the levels of MDA in OSCC patients of both saliva and blood 
simultaneously. Decreased GPx levels in blood were found in most of the studies of 
oral cancer patients but a few studies have also shown increased levels. There is 
scarcity of literature for the studies on salivary levels of GPx in oral cancer patients. 
Moreover, no study has been done to assess the blood and salivary levels of GPx 
simultaneouly in blood and saliva in OSCC. Therefore, the present study has made an 
attempt to evaluate the levels of MDA and GPx in both blood and saliva of OSCC 
patients and to compare with that of the healthy controls and to establish the 
diagnostic efficacy of saliva in evaluating salivary levels of MDA and GPx in OSCC 
patients.  
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AIM  
          To estimate the levels of MDA and GPx in both blood and saliva of OSCC 
patients. 
 
 OBJECTIVES OF THE STUDY 
 To determine the levels of MDA in both blood and saliva of OSCC patients 
and to compare it with that of healthy controls 
 To determine the levels of GPx in both blood and saliva of OSCC patients and 
to compare it with that of healthy controls 
 To correlate MDA and GPx in blood and saliva of OSCC patients. 
 To determine the sensitivity and specificity of these markers in blood and 
saliva of OSCC. 
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ORAL CANCER 
Cancer is the major cause of morbidity and mortality all over the world. It is 
one of the main causes of death in all countries with its relative position varying with 
age and sex. The sixth most common cancer in the world is oral and oropharyngeal 
carcinomas (Shenoi et al., 2012). In India, Oral cancer is among the top three types of 
cancers. The incidence of oral cancer is highest in India, South and Southeast Asian 
countries. In India, oral squamous cell carcinoma (OSCC) constitutes about 90-95% 
of all the oral cancers. The lifetime risk for mortality due to cancer in India for both 
males and females is estimated to be 61% (Varshitha, 2015). 
A number of etiological factors has been attributed to the high incidence of 
oral cancer in India. The common causes for oral cancer are tobacco consumption 
habit among the patients either as smokeless tobacco or smoking, alcohol 
consumption. The other causes for oral cancer are positive family history of oral 
cancer, viral infections like HPV, poor oral hygiene (Varshitha, 2015). 
However, not all the people who follow these habits develop OSCC. There 
may be a few genetic characteristics specific to an individual or certain other 
environmental factors which may either offer protection against OSCC, or may 
predispose to or even promote OSCC (Feller, 2012). 
According to World Health Organization (WHO), in developing countries, in 
males, carcinoma of oral cavity is the sixth commonest cancer after lung, prostate, 
colorectal, stomach and bladder cancer, while in females, it is the tenth commonest 
site of cancer after breast, colorectal, lung, stomach, uterus, cervix, ovary, bladder and 
liver (Mehrotra and  Yadav, 2006). 
The international agency for research on cancer (IARC) confirmed that 
smoking of various forms of tobacco is carcinogenic in humans.
 
There is increased 
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exposure to carcinogenic agents such as tobacco-specific nitrosamines released from 
tobacco chewing with betel quid and to nitrosamines derived from areca nut alkaloids. 
Furthermore, reactive oxygen species (ROS) involved in multistage carcinogenesis, 
are also generated in considerable amounts in the oral cavity during chewing/smoking 
(Mehrotra and Yadav, 2006). 
 
OXIDATIVE STRESS AND REACTIVE OXYGEN SPECIES 
The oxygen supply is absolutely essential for the existence of higher 
organisms. Paul Bert (1878) showed that oxygen in high concentrations could damage 
brain, lungs and other organs (Choudhari et al., 2014). In 1954, Gerschman and 
colleagues for the first time proposed that damaging effects of oxygen could be 
attributed to formation of oxygen free radical (Gerschman et al., 1954). 
A free radical is defined as a molecule or a molecular species that contains one 
or more unpaired electrons and is capable of independent existence. ROS include both 
free radicals as well as non-radical derivatives of oxygen (Sathyanarayana and 
Chakrapani, 2006) 
The relation between free radicals and disease can be explained by the concept 
of ‘oxidative stress’. Sies defined oxidative stress as an imbalance between oxidants 
and antioxidants in favour of oxidants, potentially leading to damage. Products of 
biological damage are referred as biomarkers of oxidative stress (Choudhari et al., 
2014). 
Oxygen is required in many metabolic reactions, particularly for the release of 
energy. During these processes, molecular oxygen is completely reduced and 
converted to water. However if the reduction of oxygen is incomplete, a series of 
reactive radicals are formed, as shown below (figure 1):  
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Figure 1: Reactive radicals (in pink) formed from oxygen (Source: Google) 
 
Besides superoxide (O2
-
), hydrogen peroxide (H2O2), hydroxyl (OH
-
) radical, 
the other free radicals and ROS of biological importance include singlet oxygen(
1
O2), 
hydroperoxy radical (HOO
-
), lipid peroxide radical (ROO
-
), nitric oxide (NO
-
) and 
peroxynitrite (ONOO
-
). The common characteristic features of free radicals are 
 Highly reactive 
 Very short half life 
 Generate new radicals by chain reaction 
 Damages biomolecules, cells and tissues. 
 
FUNCTION OF ROS IN CELLS 
                   Numerous beneficial functions are performed by ROS in our body 
such as phagocytosis, apoptosis, detoxification reactions, executioner of precancerous 
cells and infections. It is involved in signaling pathways to maintain cellular 
homeostasis in the body. Also regulates many metabolic and cellular processes 
including proliferation, migration, gene expression, immunity and wound healing. 
Biochemical reactions are involved in the synthesis of prostaglandins, hydroxylation 
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of proline and lysine, oxidation of xanthine and other oxidative processes (Noori, 
2012). 
 
SOURCES OF ROS  
Free radical reacts with the nearest stable molecule, snatching its electron to 
gain stability. The attacked molecule loses its electron and becomes a free radical. The 
chain reaction cascade resulted in disruption of a living cell. 
ROS can be produced from endogenous and exogenous substances. The 
endogenous sources are mitochondria, cytochrome P450 metabolism, peroxisomes, 
and inflammatory cell activation, NADPH oxidases (NOX), cyclooxygenases, 
lipooxygenases, xanthine oxidases. Mitochondria and NADPH oxidases are two 
major contributors of endogenous ROS in cancer. 
Exogenous sources are environmental agents such as non-genotoxic 
carcinogens, various xenobiotics, ultrasound and microwave radiation. They are 
necessary for normal cellular functions but when in excess they can cause cellular 
damage and can lead to cancer (Choudhari et al., 2014). 
 
MECHANISM OF ACTION OF ROS IN CANCER  
Cancer development is characterised by progressive action of multiple events 
taking place in a single cell. It can be described by three stages: initiation, promotion 
and progression. Involvement of ROS was found in all these stages. Depending upon 
the type of radical involved and its reactivity, the effect of oxidative stress varies at 
different stage of carcinogenesis.                    
Initiation: When a normal cell sustains a DNA mutation and when proceeded 
by a round of DNA synthesis, fixation of the mutation occurs, resulting in an initiated 
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cell. This initiation by ROS is supported by presence of oxidative DNA modifications 
in cancer tissue. 
Promotion: In this stage, clonal expansion of initiated cells takes place by 
induction of cell proliferation and/or inhibition of apoptosis. This stage shows a 
strong involvement of oxidative stress. ROS can induce the expansion of mutated cell 
clones by modulating the genes linked with proliferation or cell death temporarily and 
by regulating activity of certain transcription factors such as nuclear factor kappa B 
(NFƙB), nuclear factor erythroid 2-related factor (Nrf2), hypoxia inducible fators 
(HIF) and p53 associated with the control of cell growth and oncogenesis. This results 
in NFƙB activation, followed by induction of genes, which encodes the proteins 
responsible for inhibiting apoptosis. Pro-survival functions occurs when ROS acted at 
signal-transduction level. Oxidative stress can activate extracellular signal regulated 
kinase (ERK/MEK) and phosphoinositide 3-kinase (PI3K/AKT) pathways resulting in 
inactivation of proapoptotic proteins and upregulation of antiapoptotic genes. Lower 
level of oxidative stress at this stage can stimulate cell division and thus promotes 
growth of tumor. ROS production during this stage is the main mechanism of ROS-
related tumour promotion.  
Progression: Generation of large amounts of ROS may cause mutation and 
inhibit anti proteinases, upregulate matrix metalloproteinases and injure local tissues. 
In fully developed cancer, increased levels of oxidatively modified DNA bases may 
be responsible for the genetic instability and tumor metastasis. ROS is reported to be a 
pivotal factor for triggering angiogenic response, which is essential in tumor 
metastasis (Choudhari et al., 2014).  
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ROS formed through various events and pathways, react with and damage 
cellular components and contribute to neoplastic transformation (Choudhari et al., 
2014). Simplified flowchart depicting the entire sequence of events: (figure 2). 
 
Figure 2: Mechanism of action of ROS in cancer. (Source: Choudhari et al., 2014)  
 
ROS MEDIATED DAMAGE TO BIOMOLECULES AND ITS ROLE IN 
CARCINOGENESIS 
Oxidative nuclear and mitochondrial DNA damage: 
DNA, a highly sensitive element to ROS attacks causes permanent 
modification of genetic material. This is the first step involved in mutagenesis and 
carcinogenesis.  
Following are the effects of DNA damage caused by ROS/RNS: 
 Cause structural alterations in DNA and can produce gross   
                         chromosomal alterations  
 Affects cytoplasmic and nuclear signal transduction pathways. 
 Modulates activity of proteins and genes that respond to stress  
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 Regulates genes that are related to cell proliferation, 
differentiation and apoptosis. 
 Not only they cause damage when exposed to H2O2 / other 
oxidants but also suppress DNA repair. This results in elevated DNA lesions 
and an increased risk of disease. 
 Participates in carcinogenesis via activation of proto oncogenes 
and inactivation of tumor suppressor genes  
Lack of histone proteins and its close proximity to the respiratory chain makes 
mitochondrial DNA (mtDNA) more at risk for ROS-induced oxidative damage. 
mtDNA is an important contributor to carcinogenesis as its repair is less complete 
than chromosomal DNA repair (Choudhari et al., 2014).  
 
Oxidative damage to proteins: 
Proteins, major initial cell targets of ROS is characterized by loss of histidine 
residues, oxidative scission, introduction of carbonyl groups, and formation of 
protein-cantered alkyl, R
-
, alkoxyl, RO
-
, and alkylperoxyl, ROO
-
, radicals. Protein 
oxidation is connected with formation of inter and intra-protein cross linkages 
resulting in fragmentation, cross-linking and aggregation of proteins. Amino acid 
residue side chains and DNA repair enzymes are very susceptible to attack by ROS 
and RNS, which results in increased frequency of mutations. Protein oxidation results 
in earlier formation of protein carbonyls in biological systems. Advanced oxidative 
protein products (AOPP) produced by different oxidation patterns, results in either 
NO or H2O2 production. This may result in a series of reactions with potential damage 
to cellular micromolecules (Choudhari et al., 2014).  
 
                                                                    REVIEW OF LITERATURE 
 
13 
 
Oxidative damage to lipids: 
Methylene group between two double bonds of polyunsaturated fatty acid 
(PUFA) in cell membranes are more sensitive to ROS damage (figure 3).  
                              
Figure 3: Cell membrane damage by free radicals (Source: Google). 
 
Free radical-induced peroxidation of membrane lipids occurs in 3 stages-
initiation, propagation and termination (Sathyanarayana and Chakrapani, 2006) 
 
Initiation phase: 
This step is characterized by the removal of hydrogen atom (H) from 
polyunsaturated fatty acids (LH) caused by hydroxyl radical to make water and a fatty 
acid radical. 
LH + OH
- 
                               L
-
 + H2O 
Propagation phase: 
The fatty acid radical, an unstable molecule, thereby reacts readily with 
molecular oxygen, producing peroxy radical (LOO
-
). The radical formed is also an 
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unstable species that reacts with another PUFA (LH) to form lipid hydroperoxide 
(LOOH). 
      L
-
 + O2                     LOO
- 
LOO
-
 + LH                     LOOH + L
- 
The hydroperoxides are capable of further stimulating lipid peroxidation as 
they can form alkoxy (LO
-
) and peroxyl (LOO
-
) radicals. 
2LOOH                           LO
-
 + LO2
-
 + H2O 
  LOOH                           LO
-
 + LOO
-
 + aldehydes 
 
Termination phase:  
Lipid peroxidation proceeds as a chain reaction until all the available PUFA 
gets oxidized and results in the formation of reactive aldehydes like malondialdehyde 
(MDA) and 4 hydroxy-2-nonenal (4-HNE). They have high reactivity with proteins 
and DNA. On binding to DNA, they become potentially mutagenic (Sathyanarayana 
and Chakrapani, 2006). 
 
MALONDIALDEHYDE AS A MARKER FOR LIPID PEROXIDATION 
Malondialdehyde (MDA) is an end-product formed during oxidative stress. It 
is one of the several products formed during the degradation of phospholipids in cell 
membrane. Arachidonic acid (AA), released due to the action of phospholipase-A2 is 
attacked subsequently by ROS (hydroxyl radical OH•) from mitochondria through a 
non-enzymatic reaction and lipid endoperoxide is formed (Lorente, 2013). This lipid 
endoperoxide, ruptures spontaneously and MDA is formed in the intracellular space 
(figure 4). MDA is released into extracellular space and finally into the blood.
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Figure 4: Lipid peroxidation. (Source: Sathyanarayana and Chakrapani, 2006) 
                     
MDA, a highly reactive three carbon dialdehyde, (CHO=CH2=CHO) readily 
combines with several functional groups on proteins, lipoproteins, and DNA. MDA-
modified proteins may show altered physico-chemical behavior and antigenicity and 
has been found to be mutagenic in bacterial and mammalian cells and carcinogenic in 
rats. 
Cellular damage due to free radicals can be assessed by measuring  the levels 
of these lipid peroxides. Studies have reported increased levels of lipid peroxidation 
products such as lipid hydroperoxides, 4-HNE and MDA in oral cancer and precancer 
patients. This could be due to increased free radicals, which suggests that there may 
be a relationship between free radical activity and malignancy. Along with ROS, RNS 
is also known to play role in carcinogenesis (Choudhari et al., 2014).  
 
OXIDATIVE STRESS IN ORAL CANCER AND PRECANCER 
Usage of tobacco (smoking and smokeless) and excessive consumption of 
alcohol are amongst the major risk factors for oral cancer. ROS has been implicated in 
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oral cancer development in tobacco chewers and smokers as a result of which 
oxidative stress is increased and antioxidant defences are compromised in oral cancer 
patients (Choudhari et al., 2014).  
Free radicals generated by the use of tobacco cause continuous endogenous 
damage to cellular DNA and accumulation of such damage plays an important role in 
oral carcinogenesis. The formation and stabilization of free radicals are affected by 
the heat generated while smoking as well as the change in pH of body fluids due to 
tobacco consumption. Moreover, free radicals in the saliva of tobacco users, produced 
during auto-oxidation of areca nut-polyphenols are pivotal in initiation and promotion 
of oral cancer. This establishes the role of ROS in oral cancer in tobacco users. 
Areca ingredients induce ROS and DNA adducts formation. Alkaline 
conditions in betel nut chewing are favourable for free radicals formation.  
Alcohol, regardless of the form taken, increases the risk of oral cancer as free 
radicals are produced in excessive amounts. Cytochrome P450 2E1 (CYP2E1) 
oxidizes ethanol to acetaldehyde, which is again oxidised to acetate. Chronic ethanol 
ingestion can instigate single nucleotide polymorphism of CYP2E1. Increased 
CYP2E1 activity leads to increased generation of ROS. This in turn leads to lipid 
peroxidation and formation of 4HNE, which binds to DNA to form mutagenic 
adducts.  
All the above mentioned factors causes oxidant/ antioxidant imbalance which 
elevates oxidative stress. This is accompanied by increased lipid peroxidation, 
oxidative DNA damage, damage to macro and micro-molecules of cells and 
disturbances of antioxidant defense which can induce malignant process (Choudhari 
et al., 2014). 
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ANTIOXIDANT ENZYME SYSTEM  
To mitigate the harmful effects of free radicals, the aerobic cells have 
developed antioxidant defense mechanisms. A biological antioxidant may be defined 
as a substance (present in low concentration compared to an oxidizable substrate) that 
significantly delays or inhibits oxidation of a substrate. Antioxidants may be 
considered as the scavengers of free radicals (Sathyanarayana and Chakrapani, 
2006). 
A good antioxidant should: (i) specifically quench free radicals (ii) chelate 
redox metals (iii) interact with (regenerate) other antioxidants within the “antioxidant 
network” (iv) have a positive effect on gene expression (v) be readily absorbed (vi) 
have a concentration in tissues and biofluids at a physiologically relevant level (vii) 
work in both the aqueous and/or membrane domains (Valko et al., 2006). 
There are different ways of classifying antioxidants (Sathyanarayana and 
Chakrapani, 2006): 
I. Antioxidants in relation to lipid peroxidation 
A) Preventive antioxidants - blocks the initial production of free 
radicals. Eg: Catalase, Glutathione peroxidase. 
B) Chain breaking antioxidants – inhibits the propagative phase of 
lipid peroxidation. Eg: Superoxide dismutase, Vitamin E, Uric 
acid. 
II. Antioxidants according to their location 
A) Plasma antioxidants 
Eg: β-carotene, ascorbic acid, bilirubin, uric acid, ceruloplasmin, 
transferrin. 
B) Cell membrane antioxidants. Eg: α-tocopherol. 
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C) Intracellular antioxidants 
                         Eg: Superoxide dismutase, Catalase, Glutathione peroxidase. 
III. Antioxidants according to their nature & action 
A) Enzymatic antioxidants 
Eg: Superoxide dismutase, Catalase, Glutathione peroxidase, 
Glutathione reductase 
B) Non-enzymatic antioxidants 
a) Nutrient antioxidants  
Eg: α-tocopherol, carotenoids (β- carotene), ascorbic acid, 
selenium.  
b) Metabolic antioxidants  
Eg: Glutathione, ceruloplasmin, albumin, bilirubin, transferrin, 
ferritin, uric acid                                         
The most efficient enzymatic antioxidants involve Superoxide dismutase 
(SOD), Catalase (CAT) and Glutathione peroxidase (GPx). The major reactions of 
these enzymes are outlined below: 
 SUPEROXIDE DISMUTASE  
SOD is the first line of defense to protect cells from the negative effects of 
superoxide (O2
-
) as it converts O2
-
 to hydrogen peroxide and O2. Its catalytic function 
was discovered by Joe Mc Cord and Irwin Fridovich in 1968. SOD is grouped as 
Cu/Zn SOD, Mn SOD and Fe SOD, depending on the metal ion content. Its activity is 
observed extracellularly as well as intracellularly in mitochondria and cytosolic 
compartment. SOD activity varies and the highest levels are seen in liver, adrenal 
gland, kidney and spleen (Patekar et al., 2013). 
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Three different enzyme isoforms of SOD were identified in mammals - SOD1, 
SOD2 and SOD3. SOD1 contains Ra and Zn in its catalytic centre and was found in 
cytoplasm, nuclear compartments and in lysosomes. SOD2, a homotetramer, presents 
Mn as cofactor. It has been localized in mitochondria and has a role to play in the 
promotion of cellular differentiation and tumorigenesis. It provides protection of 
pulmonary toxicity induced by hyperoxia. SOD3, which is also a homotetramer, was 
localized in extracellular fluids like human plasma, lymphatic fluid and cerebrospinal 
fluid. (Iannitti et al, 2012) 
 
CATALASE 
CAT is a major primary antioxidant defense component catalyzes the 
decomposition of hydrogen peroxide, produced by SOD, into water and oxygen. 
Chemically, it is a tetramer composed of four polypeptide chains containing four 
porphyrin heme groups. High amounts of CAT have been localised in peroxisomes, 
microsomes and cytosol of hepatocytes. Kidney and red blood cells have also known 
to show its increased activity. (Patekar et al, 2013). 
 
GLUTATHIONE PEROXIDASE 
In 1957, Gordon C. Mills discovered an enzyme, glutathione peroxidase 
(GPx), which protected hemoglobin from oxidative breakdown by hydrogen peroxide. 
It is one of the most essential of antioxidative defence mechanisms (Sachdeo and 
Mody, 2011). 
They are classified as selenium dependent (GPx) and selenium independent 
(Glutathione-S-transferase, GST) and are found to be present intracellularly in the 
cytosol and mitochondrial matrix (Patekar et al, 2013). They vary from each other by 
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the number of subunits, the bonding nature of the selenium at the active centre and 
their catalytic mechanisms. Humans have four different Se-dependent glutathione 
peroxidases. All GPx enzymes are known to add two electrons to reduce peroxides by 
forming selenoles (Se-OH). The antioxidant properties of these selenoenzymes allow 
them to eliminate peroxides as potential substrates for the Fenton reaction.  
GPx has a high degree of affinity for H2O2 than CAT. It reduces and breaks 
down not only H2O2 but also lipid peroxide (LOOH) by catalyzing a redox reaction 
with reduced glutathione (GSH), which serves as an electron donor. During the GPx-
catalyzed reaction, GSH is converted to its oxidized disulfide form (GSSG), which 
has a decreased ability to reduce peroxide. GSH can be regenerated from GSSG by 
glutathione reductase (GR), using reduced nicotinamide adenine dinucleotide 
phosphate (NADPH). During the reaction, NADPH is oxidized to NADP
+
 and 
NADPH is regenerated through the pentose phosphate pathway. Therefore, GPx-
dependent redox cycle functions as a cellular antioxidant mechanism (figure 5) 
(Higuchi, 2014)
 
Figure 5: The antioxidant enzyme system (G-SH-reduced glutathione; GS-SG-
oxidized glutathione) (Source: Google)  
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The aberrant expression of this enzyme is induced by oxidative stress and has 
been associated with a variety of pathologies such as hepatitis, HIV, skin, kidney, 
breast and intestine cancer (Iannitti et al., 2012).  
 
OXIDANTS AS BIOMARKERS IN ORAL CANCER AND PRECANCER 
As ROS have a short half-life (seconds), its detection is often difficult. 
Specific ROS can be assessed in tissue at cellular level. Another way of measuring 
these biomarkers is by quantification of the oxidative damage of biomolecules in 
saliva, blood or urine. Stable, specific, or nonspecific derivatives such as lipid 
peroxidation products, amino acid oxidation products and peptide oxidation products 
can be measured by changes in their fluorescence, colour, or luminescence. The most 
commonly studied marker of lipid peroxidation is MDA. Easy technique and  low cost 
of evaluation can make them versatile and useful prognostic tool for identification of 
oral cancer patients with high risk for recurrence and oral precancer patients with high 
risk for oral cancer (Choudhari et al., 2014). 
 
ANTIOXIDANTS AND CARCINOGENESIS 
Increased amounts of free radicals are formed than normal under pathological 
conditions. To combat, antioxidant defense mechanisms act at different levels to 
minimise their harmful effects. Reduced antioxidant activity associated with high 
levels of oxidative stress have been reported in different cancers of head and neck. 
Various studies in blood and tissues of oral precancer and cancer, have shown 
lowered antioxidants or antioxidant capacity, which might be due to  
 Increased utilization of antioxidants to scavenge ROS or RNS  
 Inadequate production of antioxidant enzymes 
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 Poor antioxidant defence system in cancerous environment 
 Increased destruction of antioxidants by reactive oxygen metabolites 
SALIVA AS A DIAGNOSTIC FLUID 
Plasma, whole blood, urine, respired gases, muscle, and other skeletal tissues 
have been used to measure oxidative stress markers. Saliva is one such biospecimen 
still under investigation, as it has the potential to be utilized for measuring 
antioxidants and oxidative stress related biomarkers (Evans and Omaye, 2017). 
Saliva is secreted from three major salivary glands and numerous minor 
salivary glands. The whole saliva is a complex mixture of fluids including gingival 
cevicular fluid, oral, nasal, and mucosal transudate (Humphrey and Williamson, 
2001). Oral bacteria and their metabolites, desquamated epithelial and blood cells, 
food debris and various chemical products are also present in the saliva. In healthy 
adults, saliva production is estimated to be about 0.75 - 1.5 L per day and has a pH of 
about 6.2 - 7.4. Biochemically, saliva is an aqueous solution (more than 99% is water) 
containing numerous organic and inorganic molecules. It may reflect the current 
physiological condition of the body. Therefore, it is called as “the mirror of health of 
the organism” (Farnaud et al., 2010; Yoshizawa et al., 2013).  
The exchange between plasma and saliva takes place by active transport, 
diffusion across the cell membrane by passive diffusion directed by the concentration 
gradient in the salivary ducts, which are separated from the circulation system by a 
thin layer of epithelial cells (figure 6) (Lee and Wong, 2009). Saliva can potentially 
be used for long-term monitoring of oral diseases. 
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Figure 6: Mechanism of molecular transport from serum into salivary gland ducts. A. 
Active transport. B. Passive diffusion. C. Simple filtration. D. Acinar cells actively 
pump sodium ions (Na+) into the duct. E. Duct cells pump Na+ ions back into blood. 
F. Cell membrane. G. Pore on the cell membrane. H. Intracellular space. I. Acinar cell. 
[Source: Lee and Wong, 2009]  
 
Similar to plasma and tissues, ROS and RNS in saliva play an important role 
in redox-dependent signaling and are necessary for physiological functions. 
Antioxidant enzymes such as SOD, CAT, and GPx are present in saliva (Battino et 
al., 2002). Their function is to protect oral cavity against the ill effects of ROS/RNS. 
Saliva is intended to be the first line of defense against free radicals (Tothova et al., 
2015). 
Apart from periodontitis and dental caries, there are so many oral and systemic 
disorders that were studied in relation to salivary markers of oxidative stress. Oral 
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precancerous lesions such as lichen planus and leukoplakia and patients with OSCC 
were found to be associated with higher MDA (Metgud and Bajaj, 2014). 
Some of the properties of human saliva that had attracted clinicians or 
researchers to use this non-invasive fluid are: 
 Non-invasive 
 Simple collection protocols 
 Non-infectious sample 
 Easily disposal 
 Easily transportable 
 Cost effective 
 Not subject to cultural and religious “taboos” 
 Safe and effective 
 Higher patient compliance (Khurshid and Zohaib et al., 
2016) 
STUDIES ANALYSING OXIDATIVE STRESS AND ANTIOXIDANT STATUS 
IN SYSTEMIC DISORDERS 
Schiavon and Guidi et al., 1994 measured plasma GPx in various stages of 
different renal diseases and compared it with the following indices of kidney function: 
serum creatinine, creatinine clearance, and urinary excretion of α1-microglobulin, ß2-
microglobulin, albumin and N-acetyl-ß-D-glucosaminidase. GPx appeared 
significantly reduced in most of the renal diseases and showed a significant 
correlation with most of the renal function indices. Authors have suggested that 
measurement of GPx can be used as an adjunctive index for the assessment of kidney 
alterations. 
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Bakan and Taysi et al., 2003 reported lower levels of serum GPx, SOD, GSH 
and higher NO and MDA in chronic lymphocytic leukemia  patients compared with 
the control group. However, there was no statistically significant difference in the 
parameters on the basis of stages in these patients. Authors concluded that significant 
changes in antioxidant defense system leads to enhanced action of oxygen radical, 
resulting in lipid peroxidation. 
Arana and Cutando et al., 2006 assessed oxidative stress by measuring GPx, 
GR, GSH and glutathione disulfide (GSSG) in saliva of diabetic patients and heroin 
addicts.  GPx and GR levels were significantly higher in diabetics and lower in drug 
addicts than controls. Both group of patients had significantly lower levels of GSH 
and higher GSSG than controls. Authors have suggested that saliva may be suitable 
for determining the prognosis and evolution of these diseases and its oral 
manifestations.   
Hassan and Keen et al., 2013 reported significantly higher plasma levels of 
MDA, NO and SOD and significantly lower levels of GSH and GPx in lichen planus 
of skin patients than in controls. Authors concluded that an increased lipid 
peroxidation and an imbalance in the antioxidant defense mechanism may play a role 
in its pathogenesis.  
Ayala and Munoz et al., 2014 found MDA to be significantly modified in 
alzheimer’s disease, cancer, diabetes, liver disease, parkinson’s disease.  
Khalil Arjmandi and Moslemi et al., 2016 reported a significant increase in 
MDA and a significant decrease in GPx, SOD, TAA and Se levels in the serum of 
breast cancer patients in one day before and after the end of radiation therapy.  The 
level of the CAT enzyme had no significant changes. The results showed some 
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changes in the status of TAA, SOD and GPx which are associated with age, body 
mass index and clinical stage of the disease.  
Ramadan and Hemida et al., 2017 have observed decreased preoperative 
serum level of SOD and GPx antioxidants and increased level of MDA in epithelial 
ovarian cancer. These findings were associated with advanced tumor stage. Their 
study confirmed the role of oxidative stress in development of epithelial ovarian 
cancer. 
 
STUDIES ANALYSING OXIDATIVE STRESS AND ANTIOXIDANT STATUS 
IN ORAL DISORDERS OTHER THAN PRECANCER/CANCER                      
Cimen et al., 2003 and Arikan et al., 2009 found increased MDA level and 
decreased anti-oxidant enzymes (SOD, GPx, and CAT) in recurrent aphthous 
stomatitis patients.  
Sarode and Shelar et al., 2012 evaluated salivary MDA in healthy adults, 
matched for gender and age, with and without dental caries. MDA values were 
increasing with higher oral hygiene index but were not statistically significant. 
Authors have concluded that there is an association between presence of dental caries 
and salivary MDA levels.  
Miricescu and Totan et al., 2013 in a study of chronic periodontitis showed a 
significantly higher levels of salivary MDA & lower levels of salivary GPx when 
compared to control group.  
Kurku and Kacmaz et al., 2015 investigated oxidative stress in saliva of 
smokers along with their serum and found that the total oxidant stress, oxidative stress 
index, MDA and NO levels were found to be higher in the serum samples, and the 
levels of total sulfhydryl groups were lower in smokers compared with the controls. 
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Among the smokers, salivary MDA levels were higher before and after smoking, GPx 
levels were lower than the controls and salivary NO levels after smoking were higher 
than both those of the control group and the levels before smoking. They have 
concluded that the saliva samples can also be useful in showing oxidant-antioxidant 
balance in smokers. 
 
STUDIES ANALYSING OXIDATIVE STRESS AND/OR ANTIOXIDANT 
STATUS IN BLOOD OF PRECANCEROUS AND OSCC PATIENTS 
Beevi et al., 2004 analyzed the blood levels of lipid peroxidation products 
(MDA and lipid hydroperoxide), enzymatic (SOD, CAT, GPx) and non enzymatic 
(GSH, Vitamin E & Vitamin C) antioxidants and nitric oxide products[nitrite (NO2
–
), 
nitrate (NO3
–
) and total nitrite (TNO2
–
)] of 15 OSCC patients with clinical stage III/IV 
with age and sex matched healthy subjects. Nitric oxide products were significantly 
elevated, whereas enzymatic and non-enzymatic antioxidants were significantly 
lowered in OSCC patients. They have concluded that oxidative stress is increased and 
antioxidant defenses were compromised in OSCC. A weak antioxidant defense system 
makes the mucosal cells more vulnerable to the genotoxic effect of ROS. This creates 
an intracellular environment more favorable for DNA damage and disease 
progression. 
The findings of the studies conducted by Manoharan et al., 2005, Sharma 
et al., 2009, Srivastava et al., 2012, Shilpashree et al., 2013 correlated with the 
findings of the study done by Beevi et al., 2004. They have proved that TBARS level 
gradually increased whereas antioxidants level gradually reduced with increasing 
stages of oral cancer patients.  
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Sabitha and Shyamaladevi et al., 1999 analyzed SOD, catalase, GPx, GR, 
GST, glucose-6-phosphate dehydrogenase (G6PDH) and MDA levels from the blood 
samples of stage III oral cancer patients before initiating radiotherapy and after the 
sixth week of radiotherapy. MDA showed a significant increase and antioxidant 
enzymes showed a significant decrease in untreated and irradiated oral cancer patients 
when compared with normal subjects, representing the lack of antioxidant defense. 
Radiation induces lipid peroxidation by inactivating the antioxidant enzymes, thereby 
rendering the system inefficient in management of the free radical attack. Thus, the 
degree of radiation affects the extent of the depression of the antioxidant enzyme 
activities and increases lipid peroxidation. Similar findings with regard to GPx were 
reported by Sachdeo and Mody, 2011. 
Thomas and Sethupathy, 2015 evaluated the oxidative stress (TBARS) and 
antioxidant levels (SOD, catalase, GPx and GSH) levels in blood samples of healthy 
subjects, 20 oral precancer & 20 OSCC patients. Increased TBARS and decreased 
antioxidant levels were found in oral cancer patients. They also found that MDA 
levels in WDSCC was greater as compared to MDSCC and PDSCC, but this 
difference was statistically not significant. No correlation exists in lipid peroxidation 
between degrees of differentiation of malignant oral lesions. As the disease progresses 
from precancerous to cancerous state, levels of antioxidants declined further. Hence 
the authors have concluded that these antioxidant markers would be suitable for 
predicting the prognosis of oral cancer.  
The findings of the studies regarding GPx and/or MDA, conducted by Chole 
et al., 2010, Gurudath et al., 2012,  Rai et al., 2015, Misra et al., 2016, Nyamati et 
al., 2016 also correlated with the findings of the study done by Thomas and 
Sethupathy, 2015.  
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Bagul and Ganjre et al., 2013 reported significantly increased levels of SOD 
and GPx in OSCC patients compared to controls. The cause behind this may be 
increased oxidative stress and higher levels of circulating free radicals in patients with 
OSCC. The body’s defense mechanisms would play an important role in the form of 
antioxidants and try to minimize the damage, adapting itself to the above stressful 
situation. Thus the increased activity of antioxidant enzyme may be a compensatory 
regulation in response to oxidative stress.  
Khan and Malik et al., 2017 assessed various biochemical, inflammatory and 
antioxidative parameters in sera of 50 OSCC patients versus 20 healthy controls.  
Percent (%) fold increase of MDA, AGEs, AOPPs, IL-1, TNF-α. MMP-2, MMP-9 
and MMP-11 were found to be 64.85, 65.52, 68.28, 37.72, 15.97, 9.62, 42.12, 15.42 
and 30.35, respectively in OSCC as compared to controls. Authors found a significant 
decrease of GSH, SOD, CAT, Vitamin-A, Vitamin-E, and GR i.e. 73.59, 72.34, 
77.57, 26.49, 17.24 and 57.67%, respectively except GPx which was 75.57 times 
increased in OSCC patients.  
Evaluation of oxidant–antioxidant status in blood and tumor tissue samples in 
OSCC patients in comparison with the healthy controls by Gokul et al., 2010, Huo et 
al., 2014 showed similar findings. MDA and NO were significantly elevated in the 
blood and tissue samples of OSCC patients. In tissues, SOD and CAT were 
significantly reduced while in erythrocytes, reduced CAT and raised SOD was seen. 
They concluded that this oxidant–antioxidant imbalance may be considered as one of 
the factors responsible for pathogenesis of cancer. Findings of Korde et al., 2011 with 
regard to MDA were similar to the above mentioned studies.  
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STUDIES ANALYSING OXIDATIVE STRESS AND/OR ANTIOXIDANT 
STATUS IN SALIVA OF PRECANCEROUS AND OSCC PATIENTS 
Rai et al., 2006 analyzed the salivary samples of lipid peroxidation product 
(MDA) in 25 cases of leukoplakia, 47 cases of OSMF, 21 cases of candidiasis, 67 
cases of dental caries, 62 cases of oral cancer and 50 healthy subjects. They have 
found significantly elevated levels of salivary MDA in periodontitis, leukoplakia, 
OSMF and cancer as compared to controls. These findings indicate a role of free 
radicals in its pathogenesis. 
Similar findings were reported by Kaur et al., 2016, who analyzed oxidative 
DNA and lipid damage using salivary 8-OHdG, MDA, and vitamins C and E in OLP, 
oral leukoplakia, OSMF, OSCC and controls. Significantly higher levels of salivary 8-
OHdG and MDA and lower levels of vitamins C and E were found in OSCC and 
precancer patients compared to healthy controls. Authors concluded that instead of 
individual biomarker approach, a combination of 8-OHdG, MDA, vitamin C, and 
vitamin E had a high specificity and sensitivity for the diagnosis of oral pre-cancer 
and OSCC. 
Shivashankara and Kavya, 2011 also found that changes correlated with 
progression of cancer as evident by more pronounced changes in WDSCC, compared 
to MDSCC and premalignant lesions. Oxidative stress is involved in etiopathology of 
oral cancer, as evident from elevated MDA and decreased glutathione. Authors 
concluded that the salivary parameters could be of use in diagnosis and prognosis of 
oral cancer.  
Vlkova et al., 2012 compared salivary markers of oxidative and carbonyl 
stress such as TBARS, AOPP, advanced glycation end products (AGEs) and TAC in 
16 patients with oral premalignant lesions (leukoplakia, lichen planus, erythroplakia) 
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and age-matched healthy controls. Significantly higher salivary TBARS and AGEs 
and lower TAC and expression of SOD were found in patients than in controls. No 
differences were found in AOPP. Markers of lipoperoxidation and carbonyl stress 
were increased in patients with oral premalignant lesions. Authors concluded that 
decreased antioxidant status potentially due to decreased expression of antioxidant 
enzymes might be responsible for these findings. 
Similar study conducted by Agha-Hosseini  et al., 2012 in the salivary MDA, 
TAC & 8-OHdG of OLP, OSCC and controls revealed no significant differences in 
TAC and MDA levels between OLP and control, and also between OLP and OSCC 
patients. MDA and 8-OHdG were significantly higher but TAC was lower in OSCC 
patients than control. 
Shetty et al., 2014 evaluated salivary MDA in 65 healthy controls, 115 
potentially malignant disorders (PMD) and 50 OSCC patients.  A consistent elevation 
in the levels of salivary MDA was observed in controls with tobacco related habits, 
PMD and in OSCC. The authors have concluded that salivary MDA analysis can be 
used as an efficient, noninvasive tool for the early diagnosis of PMD and OSCC for 
planning comprehensive treatment protocol. 
Shankarram et al., 2015 assessed oxidative stress status by measuring TAC, 
GPx, SOD, 8-OHdG and MDA in saliva of periodontitis, oral cancer and healthy 
controls. Highly significant elevation of all oxidative stress marker levels except for 
that of SOD over healthy group. Oral cancer showed increased levels. 
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STUDIES ANALYSING OXIDATIVE STRESS AND/OR ANTIOXIDANT 
STATUS IN BOTH BLOOD AND SALIVA OF PRECANCEROUS AND OSCC 
PATIENTS 
Ergun et al., 2011 assessed the oxidative stress (MDA) and antioxidant profile 
(TAA) in 21 recently diagnosed OLP and healthy controls using serum and salivary 
samples. Lower serum TAA and higher salivary MDA was seen in OLP. A significant 
correlation was found between serum and saliva TAA in patients with OLP and in the 
control group. Significant correlation was also found between serum and saliva MDA 
values in control group. A significant inverse correlation was found between salivary 
MDA and TAA values in the control group. 
Ganesan and Kumar, 2014 assessed the varying levels of lipid peroxides 
(MDA) in saliva, serum and tissue in 10 oral pre cancer and 20 OSCC and also 
various forms of tobacco usage with sex as an added parameter. Significantly elevated 
levels of MDA were seen in saliva, serum and tissue in OSCC followed by oral 
leukoplakia when compared to controls. The results clearly indicate the increase in 
lipid peroxidation in oral pre cancer and oral cancer with no significant difference 
between gender groups. Authors correlated the increase in salivary concentration of 
MDA with increase in serum. These findings reinforce the concept that saliva is 
available, easy to obtain and relatively risk free diagnostic biofluid for assessing 
biomarkers. 
Metgud and Bajaj, 2014 also found enhanced MDA levels & decreased GSH 
levels in saliva and serum of oral leukoplakia and OSCC patients as compared to 
controls, indicating that tumor processes cause an imbalance of oxidant-antioxidant 
status in cell structures. 
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Rasool et al., 2014 estimated lipid peroxidation and antioxidant status in 
OSCC patients & compared the sensitivity and specificity of circulating biomarkers 
(MDA, Sialic acid, CAT, SOD, GSH and Neuraminidase) with β-2 microglobulin (β-
2MG) at different thresholds in blood and saliva using receiver operating 
characteristics (ROC) curve design. MDA and Sialic acid were significantly increased 
in plasma of OSCC patients as compared to controls whereas antioxidant level was 
significantly decreased. ROC analysis indicated that MDA in saliva is a better 
diagnostic tool as compared to MDA in blood and β-2MG in blood is better diagnostic 
marker as compared to β-2MG level in saliva. 
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SOURCE OF DATA 
Data was collected from patients visiting the cancer centres in Trichy, 
Thanjavur and Coimbatore. Informed consent (Annexure I) was obtained from all the 
patients before collection of samples. The study was performed after obtaining 
approval from the institutional ethical committee. 
METHOD OF COLLECTION OF DATA   
The sample for the present study comprised a total of 50 patients of both sexes 
with an age distribution between 38 and 75 years and were divided into two groups of 
25 patients each. 
Study group: Patients who were histopathologically diagnosed with OSCC (n = 25) 
Control group: Normal healthy individuals with clinically normal oral mucosa (n = 
25)  
INCLUSION CRITERIA 
Histopathologically diagnosed new cases of OSCC were included in the study 
group. 
EXCLUSION CRITERIA 
 Patients undergoing treatment such as chemotherapy and radiotherapy. 
 Patients with any other systemic disorders. 
 Patients under antioxidants. 
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METHODOLOGY 
After obtaining an informed consent (Annexure-I), patients from both the 
groups were subjected to thorough clinical examination. Each patient’s complete 
medical, dental history and clinical photographs were recorded. Following procedures 
were done in each patient of both the groups. 
1. Collection of blood 
2. Collection of saliva 
MATERIALS REQUIRED 
 Disposable syringe 
 Heparinised tubes for collecting blood 
 Clot activator tubes 
 Plain test tubes 
 Sterile container for saliva 
 Cooling centrifuge 
 Micropipettes with plastic disposable pipette tips  
 Water bath 
 Eppendorf tubes 
 Cuvettes  
 Ransel glutathione peroxidase enzyme kit 
 Reagents for malondialdehyde estimation  
 Distilled water 
 Beaker 
 Stirrer 
 Measuring cylinder 
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 Test tube stand 
 Spectrophotometer 
 Auto analyzer 
SAMPLE COLLECTION – BLOOD 
 Under aseptic precautions, 5ml of venous blood was collected from 
antecubital vein of all the subjects using sterile disposable syringe. 
 Haemolysed and lipemic samples were avoided. 
PROCESSING OF BLOOD SAMPLES 
 2 ml of whole blood was transferred to a heparinized tube and the rest 3ml was   
     transferred to a clot activator tube. 
 Serum separated by centrifugation (3000 rpm for 15 min) of clot activator   
     tubes was stored at -80
0
C until analysis, to estimate MDA by thiobarbituric   
     acid method by using spectrophotometer.  
 For GPx estimation, dilute 1 volume of the hemoglobin reagent with 4   
    volumes of redistilled water. 
 Dilute 0.05 ml heparinized whole blood with 1 ml diluting agent (R3)   
     provided in the antioxidant enzyme kit; incubate for 5 minutes and add 1 ml   
    of Hemoglobin reagent.  
 Samples were then centrifuged in a cooling centrifuge and the supernatant was   
     stored at ‑800C until analysis of GPx by Ransel antioxidant enzyme kit   
     provided by RANDOX Laboratories Ltd (Antrim, United Kingdom) and   
     samples were processed on Rx Monza automated analyzer. 
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SAMPLE COLLECTION - SALIVA 
5ml of unstimulated salivary sample were collected from each subject between 
8-11 am to avoid circadian variations.  
Patients were given detailed information about the collection protocol: 
 Refrain from eating or drinking atleast 90 minutes prior to salivary collection. 
 Rinse mouth with distilled water prior to collection of sample. 
 To sit in a comfortable position with eyes open and head tilted slightly 
forward. 
 Avoid swallowing and oral movements during collection 
 To pool the saliva in the floor of the mouth and to drain passively for 10 
minutes over the lower lip into a sterile plastic container. This was done until 
5 ml of saliva was obtained. 
PROCESSING OF SALIVA SAMPLES 
Saliva samples were immediately centrifuged (1000 g, 10 minutes) at 4°C to 
remove cell debris. The resulting supernatants were immediately transferred to 2 
separate aliquots:  
1
st
 group of aliquots were used for estimating MDA. 
2
nd
 group of aliquots were used for estimating GPx. 
The resulting supernatants were immediately deep-frozen at –80°C and stored 
for later analysis. GPx was assayed using the Ransel antioxidant enzyme kit provided 
by RANDOX Laboratories Ltd (Antrim, United Kingdom) and samples were 
processed on Rx Monza automated analyzer. MDA was estimated using thiobarbituric 
acid method by using spectrophotometer. 
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ESTIMATION OF GLUTATHIONE PEROXIDASE 
This method is based on that of Paglia and Valentine, 1967. GPx catalyses the 
oxidation of GSH by Cumene Hydroperoxide. In the presence of GR and NADPH the 
oxidised Glutathione (GSSG) is immediately converted to the reduced form with a 
concomitant oxidation of NADPH to NADP
+
. The decrease in absorbance at 340 nm 
is measured.  
Reaction principle: 
                                  GPx 
                2GSH + ROOH      --   ROH + GSSG + H2O 
 
                                                GR 
      GSSG + NADPH + H+   ----  NADP+ + 2GSH 
 
 
Reagent components and concentration: 
 
   
           Contents 
     
Concentration 
R 1a. Reagent 
 
Glutathione  
 
 
 
           4  mmol/l 
Glutathione reductase 
 
      ≥ 0.5 U/l 
NADPH 
 
      0.34  mmol/l 
R 1b. Buffer  
 
Phosphate buffer 
 
 
 
 0.05mol/l; pH 7.2        
            
 EDTA 
 
        4.3  mmol/l 
R2 Cumene hydroperoxide 
 
       0.18 mmol/l 
R3 Diluting agent  
 
Reagents preparation: 
 One vial of reagent R 1a was reconstituted with 6.5 ml of buffer R 1b. 
 10 microlitre R2 was diluted with 10 ml of saline and mixed thoroughly by 
shaking vigorously.  
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 The contents of one vial of diluting agent R3 was reconstituted with 200 ml of 
redistilled water. 
Procedure: 
 Select GPx in the Run Test screen and carry out a water blank as instructed. 
 Pipette into a test tube:  
 
Sample 
 
    10 μl 
 
Reagent R1 
 
  500 μl 
 
Cumene R2 
            
    20 μl 
 
Mix and aspirate into the analyser. The values were expressed in U/L. 
 
ESTIMATION OF MALONDIALDEHYDE 
MDA can be measured as Thiobarbituric Acid Reactive Substances (TBARS). 
First used in 1978, the measure of TBARS is still a commonly used and convenient 
method of determining the relative lipid peroxide content of biological samples sets. 
Lipids are both most likely to form peroxides and the most reactive in the TBARS 
assay. 
 Principle:  
Free MDA is typically quite low, requiring release of MDA by acid treatment 
of proteins present in the biological samples and breakdown of peroxides by heat and 
acid to produce a MDA-TBA adduct (figure 6) that absorbs light at 530-540 nm. The 
intensity of the color at 535 nm corresponds to the level of lipid peroxidation in the 
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sample. Removal of protein by precipitation eliminates potentially interfering amino 
acids that may react with Thiobarbituric acid (TBA). 
   
        
 
Figure 7: Reaction between MDA and TBA to form the MDA-TBA adduct (Source: 
Google).  
 
Reagents:  
 N/12 sulphuric acid (0.083N) -------> 0.23 ml of 36 N sulphuric acid / 100 ml 
of distilled water.  
 10% / 10g of Trichloroacetic acid (TCA) in 100 ml of distilled water. 
 Thiobarbituric acid (TBA) 
          A mixture of equal volume of 0.67% of TBA aqueous (670 mg/50 ml of 
distilled water).  
 Butanol (n-butanol) used for extraction and blank. 
Procedure: 
 Around 0.25 ml serum was mixed thoroughly with 0.25 ml of 10 % TCA and 
mixture was allowed to stand for 5 minutes at room temperature.  
 This was further centrifuged at 3000 rpm for 10 minutes and the supernatant 
was discarded.  
 The precipitate collected was washed twice with dilute sulfuric acid.  
 About 1 ml of N/12 dilute sulfuric acid was added to the tube containing 
precipitate and was mixed well with 0.15 ml of TCA reagent. 
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 This was further centrifuged at 3000 rpm for 10 minutes and the supernatant 
was discarded. 
  Mix with 2 ml of distilled water and 1 ml of TBA reagent (TBAR).  
 Reaction mixture was heated in boiling water bath at 95oC for 1 hour and 
allowed to cool with tap water. 
  Then 3.5 ml of n-butyl alcohol was added and centrifuged at 3000 rpm for 15 
minutes. 
  Butanol layer was taken from tube and absorbance of butanol layer was 
measured at 530 nm by spectrophotometer against blank using distilled water. 
  Same procedure was followed for MDA analysis in saliva.  
Calculation:  
Serum/salivary lipid peroxides in terms of MDA =      
              
                   
  
                                                                               =           μ     , where 
A = absorbance. 
 
 
STATISTICAL METHODS 
All the parameters were tabulated for statistical significance using Statistical 
Package for Social Science (SPSS) software. The differences in the levels of MDA 
and GPx in OSCC and control group were statistically analyzed using T test, followed 
by Pearson correlation coefficient test to assess the association between the 
parameters in blood and saliva and Receivers operating characteristic (ROC) curve 
analysis to determine sensitivity and specificity. 
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                                  ARMAMENTARIUM
      
Figure 8: Materials used for sample collection and analysis.  
 
      
 
Figure 9: Autoanalyzer                                   Figure 10: UV visible spectrophotometer 
 
 
                           
Figure 11: Saliva and blood samples  
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Figure 12: Placement of tubes for centrifuging.  
 
Figure 13: Photograph showing Glutathione peroxidase enzyme estimation kit.  
 
 
Figure 14: Placement of reagents and samples for Glutathione peroxidase estimation 
in analyzer.  
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Figure 15: Photograph showing reagents used for Malondialdehyde estimation. 
 
 
 
                     
  
Figure 16: Mixture was heated in a boiling water bath and a pink coloured complex 
was formed.  
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Table - 1 
   DESCRIPTIVE STATISTICS FOR MDA LEVELS IN BLOOD OF BOTH 
STUDY AND CONTROL GROUPS 
 
    
     GROUP  
  
N 
   
  MEAN    
 (μmol/L) 
 
STANDARD 
DEVIATION 
 
MINIMUM  
    (μmol/L) 
 
MAXIMUM   
    (μmol/L) 
 
CASES 
 
 
25 
 
  13.3292 
 
     1.58981 
 
11.03 
 
    15.97 
 
CONTROLS 
 
 
25 
 
  3.2896 
 
     0.91864 
 
 2.30 
 
     4.74 
         μmol/L = micromoles / litre                     
                       
      The mean value of MDA levels in blood of OSCC patients and in control group   
      were 13.3292 μmol/L and 3.2896 μmol/L respectively. 
 
Table - 2 
  COMPARISON OF MDA LEVELS IN BLOOD OF STUDY GROUP WITH 
CONTROL GROUP  
 
 
Comparison groups       
 
 
 ‘t’ value 
 
    P value 
 
 
Controls and Cases              
  
 
   -27.339 
 
      0.000 
 
T test was used for the comparison of mean blood levels of MDA between the 
control and the study groups and the difference was found to be highly significant 
( p < 0.01).  
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                                                              Table -3 
     DESCRIPTIVE STATISTICS FOR MDA LEVELS IN SALIVA BOTH 
STUDY AND CONTROL GROUPS 
 
    
     GROUP  
   
  N 
   
  MEAN   
(μmol/L) 
 
STANDARD 
DEVIATION 
 
MINIMUM   
   (μmol/L) 
 
MAXIMUM  
    (μmol/L) 
 
CASES 
 
 
 25 
 
   9.2892 
 
    0.76631 
 
8.27 
 
10.67 
 
CONTROLS 
 
 
 25 
 
   2.7244 
 
    0.95610 
 
1.55 
 
4.53 
         μmol/L = micromoles / litre  
    
        The mean value of MDA levels in saliva of OSCC patients and in control group   
        were 9. 2892 μmol/L and 2.7244 μmol/L  respectively.    
              
Table - 4 
  COMPARISON OF MDA LEVELS IN SALIVA OF STUDY GROUP WITH 
CONTROL GROUP  
 
 
Comparison groups       
 
 
 ‘t’ value 
 
  P value 
 
 
Controls and Cases              
  
 
   -26.789 
 
   0.000 
       
T test was used for the comparison of mean salivary levels of MDA between the 
control and the study groups and the difference was found to be highly significant 
(p < 0.01).  
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Table - 5 
  DESCRIPTIVE STATISTICS FOR GPX LEVELS IN BLOOD OF BOTH 
STUDY AND CONTROL GROUPS 
    
    GROUP  
 
  N 
    
  MEAN      
    (U/L) 
 
STANDARD 
DEVIATION 
 
MINIMUM   
     (U/L) 
 
MAXIMUM   
     (U/L) 
 
CASES 
 
 
 25 
 
121.2660 
 
    21.28547 
 
   92 
 
152 
 
CONTROLS 
 
 
 25 
 
219.2948 
 
    28.88628 
 
    171.53 
 
260 
          U/L = units per litre               
          The mean value of GPx levels in blood of OSCC patients and in control group   
          were 121. 2660 U/L and 219.2948 U/L respectively. 
 
 
Table - 6 
       COMPARISON OF GPX LEVELS IN BLOOD OF STUDY GROUP WITH 
CONTROL GROUP  
 
Comparison groups       
 
 
 ‘t’ value 
 
   P value 
 
 
Controls and Cases              
  
 
13.660 
 
    0.000 
       
T test was used for the comparison of mean blood levels of GPx between the 
control and the study groups and the difference was found to be highly significant 
(p < 0.01).  
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Table -7 
   DESCRIPTIVE STATISTICS FOR GPX LEVELS IN SALIVA BOTH 
STUDY AND CONTROL GROUPS 
 
    
    GROUP  
 
  N 
    
  MEAN 
  (U/L) 
 
STANDARD 
DEVIATION 
 
MINIMUM    
      (U/L) 
 
MAXIMUM 
      (U/L) 
 
CASES 
 
 
25 
 
  74.0104 
 
    19.76245 
 
    47.07 
 
102.90 
 
CONTROLS 
 
 
25 
 
140.0960 
 
    17.57459 
 
   116.40 
 
170 
         U/L = units per litre               
         The mean value of GPx levels in saliva of OSCC patients and in control group   
          were 74.0104 U/L and 140. 0960 U/L respectively. 
 
Table - 8 
       COMPARISON OF GPX LEVELS IN SALIVA OF STUDY GROUP WITH 
CONTROL GROUP  
 
 
Comparison groups       
 
 
 ‘t’ value 
 
  P value 
 
 
Controls and Cases              
  
 
 12.494 
 
   0 .000 
 
T test was used for the comparison of mean salivary levels of GPx between the 
control and the study groups and the difference was found to be highly significant 
( p < 0.01).  
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                                                               Table 9 
 
     CORRELATION OF GPX AND MDA IN BLOOD AND SALIVA OF OSCC   
      GROUP 
 
 
PARAMETERS 
PEARSON’S 
CORRELATION 
Value (r) 
 
     p value 
 
Blood and salivary GPx 
 
      
      0.757 
 
0.000 
 
Blood and salivary MDA 
 
       
      0.940 
 
0.000 
 
Blood GPx and MDA   
 
                  
                 -0.840 
 
0.000 
 
Salivary GPx and MDA  
      
     -0.845 
 
0.000 
       
 
     Pearson's correlation coefficient test was done to correlate MDA and GPx in blood   
     and saliva of OSCC subjects. 
 Blood and salivary GPx levels showed a strong positive correlation and p 
value was found to be statistically highly significant (p < 0.01).  
 Blood and salivary MDA levels showed a strong positive correlation and p 
value was found to be statistically highly significant (p < 0.01). 
  GPx and MDA levels in blood showed a strong negative correlation and p 
value was found to be statistically highly significant (p < 0.01). 
  GPx and MDA levels in saliva showed a strong negative correlation and p 
value was found to be statistically highly significant (p < 0.01).                                                      
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                                                   Table-10 
       SENSITIVITY AND SPECIFICITY OF MDA AND GPx IN BLOOD AND   
              SALIVA OF THE CONTROL AND PATIENTS OF OSCC 
 
Receivers operating characteristic (ROC) curves were constructed at different 
thresholds to evaluate discriminatory efficacy of the parameters between patients 
and controls in blood and saliva separately.  
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                 The area under curve (AUC) computed in saliva and blood for GPx and 
MDA was 1.00, statistically significant (P < 0.01).The optimum threshold values 
of MDA level in blood and saliva obtained were ≥ 7.88 μmol/L and ≥ 6.40 μmol/L 
respectively. The optimum threshold values of GPx level in blood and saliva 
obtained were ≤ 161.76 U/L and ≤ 109.65 U/L respectively. The sensitivity of 
MDA and GPx obtained was 100 % in saliva and in blood. The specificity record 
of MDA and GPx levels obtained were 100% in saliva and in blood. 
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Cancer is an event occurring at the genetic level and DNA damage is the final 
step resulting in carcinogenesis. Viruses, chemicals, irradiation and the genetic 
makeup of the individual are the multiple factors that play a role in carcinogenesis. 
The two important agents of DNA damage are ROS and RNS (Beevi et al, 2004). 
However, they are effectively neutralized by highly powerful cellular antioxidant 
enzymes. Oxidative stress results when the balance is lost between ROS production 
and antioxidant defense, leading to oxidative damage of the cellular macromolecules 
(Srivastava et al, 2012). 
Disruption of this delicate oxidant/antioxidant balance in the body seems to 
play a causative role in carcinogenesis. With increasing evidences, the role of 
oxidative stress is found in several human pathological conditions such as 
gastrointestinal ulcerogenesis, rheumatoid arthritis, ischemic heart disease, several 
autoimmune disorders, metabolic disorders, neurodegenerative disease and cancer. 
ROS and RNS were found to be involved in all the three stages of multistep 
carcinogenesis and can result in DNA damage, activate procarcinogens, initiate lipid 
peroxidation, inactivate enzyme systems and alter the cellular antioxidant defense 
system (Srivastava et al, 2012).  
Malondialdehyde (MDA) is a major reactive aldehyde resulting from the 
peroxidation of biological membrane PUFA. MDA is mutagenic, genotoxic agent and 
potential carcinogen in mammalian system, which readily reacts with deoxy 
nucleosides to produce adducts causing DNA damage. So, lipid peroxidation has 
gained importance because of its involvement in various diseases including cancer 
(Metgud and Bajaj, 2014) 
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Glutathione peroxidase (GPx) is one of the important enzymatic antioxidant 
involved in the protection of cells against peroxidation. It catalyses the degradation of 
H2O2 and O2. Most of its activity was found in blood within the erythrocytes and only 
1 to 2% in plasma (Sachdeo and Mody, 2011).  
Involvement of oxidative stress have been reported in oral conditions like 
lichen planus, recurrent aphthous ulcer and periodontitis. Recent studies have also 
shown the association between oxidative stress with potentially malignant disorders 
like OSMF and leukoplakia. Oral cancer has been a major concern worldwide, as it 
accounts for the sixth most common malignancy in the world (Srivastava et al, 
2012). 
The present study was carried out in 25 histopathologically diagnosed patients 
of OSCC who have not undergone any treatment and 25 normal healthy individuals. 
Saliva and blood samples were collected from all the subjects of both the groups. The 
samples were centrifuged and analysed for the following parameters: 
 Malondialdehyde 
 Glutathione peroxidase 
MDA level was evaluated by thiobarbituric acid method using 
spectrophotometry and GPx was evaluated using Ransel antioxidant enzyme kit.  
In the present study, all individuals in the study group were in the age range of 
38-75 years. Gender distribution was 18(72%) males and 7(28%) females. Most 
commonly affected site was buccal mucosa (10/25cases) followed by tongue (6/25 
cases), palate (2/25), retromolar trigone (2/25) and 1 case each in angle of the mouth 
(1/25), labial mucosa (1/25), lower lip and buccal mucosa (1/25), lower lip and angle 
of the mouth (1/25), buccal mucosa and angle of the mouth (1/25). 14(56%) cases 
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were affected with MDSCC, 9(36%) with WDSCC and 2(8%) with PDSCC. The 
results were discussed under the following headings: 
 MDA levels in blood of OSCC subjects 
 MDA levels in saliva of OSCC subjects 
 GPx levels in blood of OSCC subjects 
 GPx levels in saliva of OSCC subjects 
 MDA levels in both blood and saliva of OSCC subjects 
 GPx levels in both blood and saliva of OSCC subjects 
 Correlation of blood and salivary MDA and GPx levels in OSCC   
                        subjects.  
 Sensitivity and specificity of MDA and GPx levels in blood and saliva   
                        of OSCC subjects 
 
I. MDA LEVELS IN BLOOD OF OSCC SUBJECTS 
In the present study, the mean MDA levels in blood of healthy controls and 
OSCC patients were 3.2896 μmol/L and 13.3292 μmol/L respectively. This difference 
between the control group and study group was found to be statistically highly 
significant (p<0.01).  
Our findings correlated with several studies that have found significantly 
increased levels of MDA in oral cancer groups with differing clinical stages (Beevi et 
al., 2004,  Manoharan et al., 2005,  Sharma et al., 2009,  Gokul et al., 2010, 
Srivasatva et al., 2012, Shilpashree et al., 2013, Huo et al., 2014). Sabitha and 
Shyamaladevi, 1999 observed a significant increase (p < 0.01) in MDA levels before 
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initiating radiotherapy and a highly significant increase (p < 0.001) after radiotherapy 
in OSCC subjects.  
Our findings were in agreement with that of studies by Chole et al., 2010, 
Korde et al., 2011, Thomas and Sethupathy, 2015, Rai et al., 2015, Misra et al., 
2016 and Nyamati et al., 2016 in healthy controls, oral precancer and OSCC patients. 
They observed a statistically significant increase in serum MDA levels in oral 
precancer and oral cancer patients compared to control group. Chole et al., 2010 
concluded that oxidative stress is more intense in oral cancer and precancer and 
suggested antioxidant therapy as an adjunct in the treatment of oral precancer and 
cancer.  
Khan and Malik et al., 2017 found highly significant MDA levels (p<0.05) 
and 64.85 percent fold increase of MDA in OSCC patients compared to controls. 
The increase in MDA levels in blood as shown in this study might be due to 
the decomposition products of PUFA, a major component in the cell membranes of 
erythrocytes and other cells. PUFA is considered highly susceptible to oxidative 
attack (Srivasatva et al., 2012). Erythrocytes are exposed continuously to oxidative 
stress. Although the reducing capacity of the normal erythrocytes is greater than its 
oxidising potential, lack of antioxidant defense leads to an increase in membrane lipid 
peroxidation (Sachdeo and Mody, 2011). Oxidative attack results in alterations in 
respect to membrane’s fluidity and permeability with consequent leakage into the 
plasma. Thus, large volumes of MDA may be due to the leakage into the plasma or 
inadequate clearance of free radicals by the cellular antioxidants (Srivasatva et al., 
2012). Owing to its high cytotoxic properties, MDA modulate cell growth by 
activating signal transduction pathways, therefore acting as tumor promoters and co-
carcinogenic agents (Metgud and Bajaj, 2014).  
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II. MDA LEVELS IN SALIVA OF OSCC SUBJECTS 
In the present study, mean MDA levels in saliva of healthy controls and OSCC 
patients were 2.7244 μmol/L and 9. 2892 μmol/L respectively. This difference 
between the control group and study group was found to be highly significant 
(p<0.01).  
Our findings of elevated MDA levels in saliva of OSCC patients were in  
accordance with Rai et al., 2006, Shivashankara & Kavya, 2011, Agha-Hosseini et 
al , 2012, Shetty et al., 2014 and Kaur et al., 2015 in their study of comparison 
between healthy individuals, oral precancer and OSCC.   
Warnakulasuriya et al., 2008 in a study on Japanese patients with oral 
leukoplakia observed positive staining of MDA adducts in the dysplastic epithelial 
cells. Therefore these tissue-bound MDA adducts might be the source of the salivary 
MDA (Vlkova et al, 2012).  
 
III. GPx LEVELS IN BLOOD OF OSCC SUBJECTS 
In the present study, mean GPx levels in blood of healthy controls and OSCC 
patients were 219.2948 U/L and 121.2660 U/L respectively. This decrease from 
normal to OSCC was highly significant (p<0.01).    
Our findings were in agreement with several studies that have found 
significantly decreased levels of GPx in oral cancer groups with differing clinical 
stages (Beevi et al., 2004, Manoharan et al., 2005, Sharma et al., 2009, Srivastava 
et al., 2012 and Shilpashree et al., 2013). Sabitha and Shyamaladevi, 1999, 
Sachdeo and Mody, 2011 observed a significant decrease (p < 0.01) in GPx levels 
before initiating radiotherapy and a highly significant decrease (p < 0.001) after 
radiotherapy in OSCC subjects.  
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Gurudath et al., 2012, Thomas and Sethupathy et al., 2015 and Nyamati et 
al., 2016 found the mean GPx level gradually decreased from healthy individuals to 
potentially malignant and OSCC patients and the result was statistically highly 
significant (P < 0.001).  
Decrease in GPx levels might occur as the consequence of overwhelming free 
radicals by the elevated levels of lipid peroxides. Low levels of GPx suggested that 
most cancer cell types couldn’t detoxify hydrogen peroxide (Gurudath et al., 2012). 
Decrease in antioxidant enzymes may also be due to increased scavenging by lipid 
peroxides as well as sequestration by tumor cells to meet the demands of a growing 
tumor (Shilpashree et al., 2013).  
Insufficient power of a depleted antioxidant defense system for a prolonged 
time might also result in enhanced lipid peroxidation. According to Blunt and 
Fridovich, GPx may be inactivated by superoxide anions during oxidative stress 
conditions and toxic ligands such as MDA could partially inhibit GPx inactivity. 
Disturbed antioxidant enzymes status might also be due to the deprivation of trace 
elements such as Copper, Manganese, Zinc and Selenium. With reduced GPx activity, 
detoxification of H2O2 to H20 remains incomplete (Sharma et al., 2009). The reduced 
level of selenium in the serum might also be a reason for the decrease in GPx activity, 
as its activity partially depends upon the selenium concentration. According to 
Etlemble et al, 1979 the efficiency of this enzyme might be impaired due to the 
circulating inhibitor of this enzyme produced by the tumor itself (Sachdeo and 
Mody, 2011).   
Bagul and Ganjre et al., 2013 found statistically significant (p<0.05) increase 
in the levels of GPx in OSCC patients as compared with control subjects. Our finding 
was not in accordance with that of Bagul and Ganjre et al., 2013, who suggested that 
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the increased GPx levels might be due to the high oxidative stress and lipid 
peroxidation in the initial stages of OSCC and increased level of free radicals in their 
body. As a compensatory mechanism body tries to increase the levels of antioxidants 
to counteract carcinogenesis. Khan and Malik et al., 2017 found greatly increased 
levels of GPx (75.57 times) in OSCC patients compared with control group. Our 
finding was not in accordance with that of Khan and Malik et al., 2017, who 
proposed that in the presence of SOD and CAT deficiency in OSCC patients, GPx 
comes into action so as to combat oxidative stress and scavenge hydrogen peroxide to 
less toxic molecules. In addition, enhanced activity of GPx converts the available 
GSH to oxidized form leaving behind insufficient active GSH levels.  
 
IV. GPx LEVELS IN SALIVA OF OSCC SUBJECTS 
In the present study, the mean levels of GPx in saliva of OSCC patients and in 
control group were 74.0104 U/L and 140.0960 U/L respectively.This decrease from 
normal to OSCC was highly significant (p<0.01).    
Using the keywords: Glutathione peroxidase, saliva, oral cancer, Oral 
squamous cell carcinoma in Google and PubMed search, only one study was available 
that estimated the levels of Glutathione peroxidase in saliva of periodontitis, oral 
cancer patients and healthy controls using ELISA kits (Shankarram et al., 2015).  
Shankarram et al., 2015 in the study of periodontitis, oral cancer and healthy 
controls assessed GPx, TAC, SOD, 8-OHdG and MDA by ELISA kits and found 
highly significant elevation of all oxidative stress marker levels in saliva except for 
that of SOD over healthy group. Our finding of decreased salivary GPx levels in 
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OSCC was in disagreement with that of Shankarram et al., 2015. This difference in 
finding might be due to:  
 Inclusion/exclusion criteria has not been mentioned. In our study, only 
histopathologically diagnosed new cases of OSCC were included. Patients already 
under chemotherapy/radiotherapy, any other systemic disorders and patients under 
antioxidants were excluded.  
 Different methodology 
 Number of patients with different histopathological grades of OSCC 
 
V. MDA LEVELS IN BOTH BLOOD AND SALIVA OF OSCC SUBJECTS   
Several studies have taken serum samples as a tool for measuring oxidative 
stress and antioxidant status, and only a few studies have taken saliva samples. Only 
limited studies exist to compare the levels of MDA in OSCC patients of both saliva 
and serum simultaneously (Ganesan and Kumar, 2014, Metgud and Bajaj, 2014 
and Rasool et al., 2014).  
Studies by Ganesan and Kumar, 2014, Metgud and Bajaj, 2014 and Rasool 
et al., 2014 reported significantly elevated levels of MDA (p<0.001) in saliva and 
serum of OSCC patients when compared to control group.  
The increased MDA levels (in saliva and serum) were not only due to tobacco 
consumption but also as a result of the magnitude of oxidative stress. This is in favour 
of the hypothesis that altered ROS metabolism in cancer cells leads to production of 
large amounts of ROS as compared to non-neoplastic cells and the suppression of the 
antioxidant system that mediate the defense mechanisms in the body (Metgud and 
Bajaj, 2014).  
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VI. GPx LEVELS IN BOTH BLOOD AND SALIVA OF OSCC SUBJECTS 
Using the keywords: Glutathione peroxidase, saliva, blood, serum, plasma, 
oral squamous cell carcinoma, oral cancer in Google and PubMed search, yielded no 
results. As no other published study was available to compare the levels of GPx in 
OSCC patients of both saliva and serum simultaneously, the statistical significance of 
our findings could not be compared. 
  
VII. CORRELATION OF BLOOD AND SALIVARY MDA AND GPx LEVELS  
         IN OSCC SUBJECTS 
In the present study, correlation between blood and salivary GPx levels was 
done and the results showed highly significant strong positive correlation. None of the 
study had correlated between blood and salivary GPx in OSCC. Hence the 
significance of our results cannot be compared or correlated. 
A highly significant strong positive correlation between serum and salivary 
MDA levels was found in the present study. Ganesan and Kumar, 2014 observed an 
increase in salivary concentration of MDA with increase in serum. But statistical tools 
were not used to justify the observation.   
The positive correlation seen between the blood and salivary levels of GPx 
and MDA might be due to passage of molecules from the blood into the saliva by 
passing through the spaces between cells by transcellular (passive intracellular 
diffusion and active transport) or paracellular routes (extracellular ultrafiltration) (Lee 
and Wong, 2009). Hence the increase in MDA levels and decrease in GPx levels in 
circulation was also reflected in saliva.  
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In the present study, blood levels of MDA and GPx showed a highly 
significant strong negative correlation. This finding was consistent with the study of 
Sharma et al., 2009. A moderate negative correlation was observed by Srivastava et 
al., 2012 but it was not statistically significant. Our findings were not in line with 
Khan and Malik et al., 2017, who observed a weak positive correlation between GPx 
and MDA.  
Similarly, salivary levels of MDA and GPx also showed a highly significant 
strong negative correlation. None of the study had correlated salivary GPx and MDA 
in OSCC, so significance of our results cannot be compared or correlated. 
The compensatory mechanism to counterbalance the effects of ROS results in 
reduced levels or activities of antioxidants and this could be the possible explanation 
for the negative correlation between MDA and GPx levels. 
 
VIII. SENSITIVITY AND SPECIFICITY OF MDA AND GPx IN BLOOD AND  
          SALIVA OF OSCC 
In order to check whether MDA and GPx levels in blood and saliva could 
discriminate between OSCC and healthy controls, a complete statistical Receiver 
Operating Characteristic (ROC) curve analysis was performed. The area under curve 
(AUC) computed in saliva and blood for GPx and MDA was 1.00, statistically 
significant (P <0.01).The optimum threshold values of MDA level in blood and saliva 
obtained were ≥7.88 μmol/L and ≥6.40 μmol/L respectively. The optimum threshold 
values of GPx level in blood and saliva obtained were ≤ 161.76 U/L and ≤ 109.65 U/L 
respectively. The sensitivity of MDA and GPx obtained was 100 % in saliva and in 
blood. The specificity record of MDA and GPx levels obtained were 100% in saliva 
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and in blood. Hence, it meant that MDA and GPx levels in saliva and blood were 
equally reliable diagnostic tests.  
Rasool et al., 2014 observed a high sensitivity (86.67 %) in saliva and low 
sensitivity (73.33%) in blood. The specificity was found to be 100% in saliva and 
90% in blood and hence MDA in saliva was considered as a better diagnostic test than 
MDA in blood. Findings with regard to MDA were partly in agreement to that of 
Rasool et al, 2014. None of the study had assessed the sensitivity and specificity for 
blood and salivary GPx in OSCC, so significance of our results cannot be compared 
and needs further research to conclude our findings.  
There were certain limitations in the present study- smaller sample size, cases 
and controls were not age/sex matched and other antioxidant enzymes were not 
estimated. A major issue was the analytical method. As the results seem to vary 
extremely between laboratories, correct reporting on the used methods in the articles 
is more important for the reproducibility and comparability of results.  
Although the present study showed significant results, the scope for further 
research remains open, as there is a paucity of similar literature for comparisons at 
present. The results should be viewed as a pilot for extending studies with larger 
sample sizes, with various clinical stages and histopathological grades of OSCC for 
more accurate results. Only then the markers can be used for prediction of 
malignancy, for early detection and prevention of cancer and preventive measures in a 
clinical setting.  
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             The present study was conducted in 25 newly diagnosed 
histopathologically confirmed cases of OSCC and 25 healthy controls. Blood and 
saliva samples were collected from all the subjects in study and control group and 
analysed for MDA and GPx. The values were tabulated and the results were 
analyzed using T test, Pearson correlation coefficient test and ROC analysis.  
The analysis showed the following results: 
 A highly significant difference was observed between the mean blood levels 
of MDA in healthy controls and OSCC patients and were found to be raised in 
OSCC with p < 0.01. 
 A highly significant difference was observed between the mean salivary levels 
of MDA in healthy controls and OSCC patients and were found to be raised in 
OSCC with p < 0.01. 
 A highly significant difference was observed between the mean blood levels 
of GPx in healthy controls and OSCC and were found to be decreased in the 
OSCC with p< 0.01. 
 A highly significant difference was observed between the mean salivary levels 
of salivary GPx in healthy controls and OSCC, and were found to be 
decreased in the OSCC with p< 0.01 
 A highly significant strong positive correlation was observed between blood 
and salivary GPx levels in OSCC subjects. 
 A highly significant strong positive correlation was observed between blood 
and salivary MDA levels in OSCC subjects. 
  A highly significant strong negative correlation was observed between GPx 
and MDA levels in blood in OSCC subjects.  
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 A highly significant strong negative correlation was observed between GPx 
and MDA levels in saliva in OSCC subjects. 
 The sensitivity and specificity of MDA and GPx were found to be 100 %,  
    both in blood and saliva.  
             Our findings of increased MDA and decreased GPx levels with a strong 
negative correlation proved that the antioxidants are depleted during the course of 
neutralizing ROS in OSCC patients. Thus, our findings reemphasized the role of 
ROS in oral carcinogenesis. Additionally, significant positive correlation between 
serum and salivary levels with high sensitivity and specificity highlights saliva as 
a valid, convenient and an equally reliable diagnostic biofluid as blood for 
measuring biomarkers of antioxidants and oxidative stress. MDA and GPx can be 
considered as potential biomarkers for assessing oxidative stress and antioxidant 
status in OSCC.  
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                                                         ANNEXURE  1 
          INFORMED CONSENT FORM  
STUDY OF MALONDIALDEHYDE AND GLUTATHIONE PEROXIDASE IN 
BLOOD AND SALIVA OF ORAL CANCER PATIENTS. 
 
 Name:                 Age/Sex:        Date: 
 
   I,                                     aged                 have been informed about my in the study: 
1. I agree to give my personal details like name, age, sex, address, previous 
dental history and the details required for the study to the best of my 
knowledge. 
2. I will cooperate with the dentist for my intra oral examination or extra oral 
examination. 
3. I permit the dentist to take saliva and  blood samples required for the study. 
4. If am unable to participate into study for reasons unknown. I can withdraw 
from the study. 
In my full consciousness and presence of mind, after understanding all the 
procedure in my own language, I am willing and give my consent to participate in this 
study. 
                                    
                                                                                        Signature / Thumb impression 
 
ஆராய்ச்சி ஒப்புதல் கடிதம் 
 
வாய் புற்று ந ாயினால் பாதிக்கப்பட்ட ந ாயாளிகளின் உமிழ்  ீர் 
மற்றும் இரத்தத்தில் மமந ான்டட ஆல்டிடைடு மற்றும் 
குளூட்நடாடதநயான் பாராகஸிநடஸ் அளவிடன ஆராய்ந்து 
அறிதல். 
 
 
மபயர்........... 
வயது............ 
பா ினம்....... 
 
என் மபயர், வயது, பா ினம்,  ான் நமற்மகாள்ளும் சிகிச்டச 
பற்றிய முழு விவரங்கடளயும் மகாடுக்க  ான் முழு மனதுடன் 
ஒப்புக்மகாள்கிநறன்.என்னுடடய வாயின் முன் பகுதி அல் து 
மவளிப்பகுதிடய மருத்துவர் பரிநசாதடன மசய்ய 
ஒத்துடைக்கிநறன்.நமற்கண்ட ஆராய்ச்சிக்காக என் உமிழ்  ீர் 
மற்றும் இரத்தம் எடுக்க அனுமதி அளிக்கிநறன்.  
ஆராய்ச்சி சம்பந்தப்பட்ட விபரங்கடள முைடமயாக புரிந்து 
மகாண்ட பிறகு என் முழு மனதுடன் இந்த ஆராய்ச்சியில் பங்கு 
மகாள்ள சம்மதிக்கிநறன். 
 
 
 
 
                                                இப்படிக்கு 
 
 
 
 
இடம்: 
நததி: 
 
 
  
 
                                                    ANNEXURE 2 
 
A. GLUTATHIONE PEROXIDASE (GPx) AND MALONDIALDEHYDE 
(MDA) LEVELS IN BOTH BLOOD AND SALIVA OF 25 OSCC PATIENTS 
        
S.NO 
                        GPx (U/L)                  MDA (μmol/L) 
      BLOOD     SALIVA    BLOOD     SALIVA 
   1. 99.23 55.23 12.43 9.09 
   2. 152.00 49.85 11.56 8.33 
   3. 106.42 52.05 13.64 9.09 
   4. 121.62 64.09 11.05 9.27 
   5. 146.12 58.14 11.03 8.71 
   6. 150.09 101.6 14.65 10.02 
   7. 143.80 102.9 15.24 8.29 
   8. 136.55 99.73 14.55 8.67 
   9. 99.00 100 12.24 8.27 
  10. 125.24 87.45 13.32 10.19 
  11. 106.76 102 14.44 9.88 
  12. 108.07 66.54 15.55 9.54 
  13. 92.03 78.37 13.36 8.94 
  14. 150.24 68.55 12.45 9.22 
  15. 149.31 48.63 14.53 10.54 
  16. 127.65 62.01 12.44 8.41 
  17. 107.33 101.2 11.21 9.31 
  18. 99.03 73.44 12.11 9.55 
  19. 92.00 56.33 11.34 8.54 
  20. 139.19 81.24 15.97 10.22 
  21. 121.24 69.55 11.66 10.58 
  22. 109.36 84.02 14.11 9.01 
  23. 148.04 47.07 15.34 8.34 
  24. 96.10 49.71 13.56 10.67 
  25. 105.23 90.56 15.45 9.55 
Mean  121.2660 74.0104 13.3292 9.2892 
  
                                                    
 
 
 
 
  
B.GLUTATHIONE PEROXIDASE (GPx) AND MALONDIALDEHYDE  
(MDA) LEVELS IN BOTH BLOOD AND SALIVA OF 25 CONTROLS 
        
S.NO 
                        GPx (U/L)                  MDA (μmol/L) 
      BLOOD     SALIVA    BLOOD     SALIVA 
   1. 199.34 155.7 3.43 2.12 
   2. 250.30 150 3.09 1.83 
   3. 198.22 120.6 2.45 2.2 
   4. 171.53 128.2 2.37 4.53 
   5. 260.00 142.3 4.47 1.55 
   6. 240.11 130.1 2.41 2.54 
   7. 242.21 117.6 2.3 3.71 
   8. 189.45 168.3 2.32 3.24 
   9. 193.61 116.8 4.56 1.77 
  10. 249.53 163.9 3.3 4.05 
  11. 259.01 131.3 4.22 2.33 
  12. 232.51 134.1 2.37 2.61 
  13. 196.45 146.3 2.81 1.78 
  14. 201.23 118.2 2.35 2.06 
  15. 210.44 128.8 3.03 4.09 
  16. 253.66 146.2 4.55 3.76 
  17. 199.72 165.6 3.38 2.33 
  18. 186.27 119.4 3.71 3.57 
  19. 181.35 170 2.34 2.44 
  20. 212.34 140.5 2.76 4.15 
  21. 197.12 155 3.56 1.57 
  22. 202.66 161.3 4.74 3.83 
  23. 257.21 134.6 2.32 2.55 
  24. 243.45 141.2 4.71 1.67 
  25. 254.65 116.4 4.69 1.83 
Mean  219.2948 140.0960 3.2896 2.7244 
  
 
 
 
